What evidence exists for BPC-157 in tendons and joints?
Updated: 2026-09-09 · Recovery: BPC-157 and TB-500
Short answer
The available evidence is mainly preclinical: cell cultures and animal models describing effects on tendon and connective tissue repair. That justifies scientific interest, not a clinical conclusion. For a specific injury in a specific person, no large controlled trial currently supports its use.
In plain English
- Animal models: repeated positive signals in tendon repair.
- Humans: only small, uncontrolled pilot studies with very few participants in total.
- A good result in a rat does not predict a good result in a person.
What we know
- Preclinical studies exist and are internally consistent; the published human evidence is minimal and uncontrolled.
- There is no regulatory approval for musculoskeletal indications.
What we don't know yet
- Dose, duration, safety and real human efficacy — all four remain unestablished.
Sources
External links to official sources or peer-reviewed studies.